These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A critical smn threshold in mice dictates onset of an intermediate spinal muscular atrophy phenotype associated with a distinct neuromuscular junction pathology. Bowerman M, Murray LM, Beauvais A, Pinheiro B, Kothary R. Neuromuscul Disord; 2012 Mar; 22(3):263-76. PubMed ID: 22071333 [Abstract] [Full Text] [Related]
3. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, Monani UR. J Neurosci; 2010 Sep 08; 30(36):12005-19. PubMed ID: 20826664 [Abstract] [Full Text] [Related]
4. Synaptic withdrawal following nerve injury is influenced by postnatal maturity, muscle-specific properties, and the presence of underlying pathology in mice. Mole AJ, Bell S, Thomson AK, Dissanayake KN, Ribchester RR, Murray LM. J Anat; 2020 Aug 08; 237(2):263-274. PubMed ID: 32311115 [Abstract] [Full Text] [Related]
5. Hyperexcitability precedes motoneuron loss in the Smn2B/- mouse model of spinal muscular atrophy. Quinlan KA, Reedich EJ, Arnold WD, Puritz AC, Cavarsan CF, Heckman CJ, DiDonato CJ. J Neurophysiol; 2019 Oct 01; 122(4):1297-1311. PubMed ID: 31365319 [Abstract] [Full Text] [Related]
6. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, Landmesser LT, Monani UR. Hum Mol Genet; 2008 Aug 15; 17(16):2552-69. PubMed ID: 18492800 [Abstract] [Full Text] [Related]
9. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH. Hum Mol Genet; 2008 Apr 01; 17(7):949-62. PubMed ID: 18065780 [Abstract] [Full Text] [Related]
12. Limited phenotypic effects of selectively augmenting the SMN protein in the neurons of a mouse model of severe spinal muscular atrophy. Lee AJ, Awano T, Park GH, Monani UR. PLoS One; 2012 Apr 01; 7(9):e46353. PubMed ID: 23029491 [Abstract] [Full Text] [Related]
17. A novel zebrafish model for intermediate type spinal muscular atrophy demonstrates importance of Smn for maintenance of mature motor neurons. Tay SH, Ellieyana EN, Le Y, Sarusie MV, Grimm C, Ohmer J, Mathuru AS, Fischer U, Winkler C. Hum Mol Genet; 2021 Nov 30; 30(24):2488-2502. PubMed ID: 34302176 [Abstract] [Full Text] [Related]
18. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy. Tseng YT, Chen CS, Jong YJ, Chang FR, Lo YC. Pharmacol Res; 2016 Sep 30; 111():58-75. PubMed ID: 27241020 [Abstract] [Full Text] [Related]